{"title":"Retraction Note: LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis.","authors":"Y-Y Zhang, M Li, Y-D Xu, J Shang","doi":"10.26355/eurrev_202504_37158","DOIUrl":null,"url":null,"abstract":"<p><p>The article \"LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis\" by Y.-Y. Zhang, M. Li, Y.-D. Xu, J. Shang published in Eur Rev Med Pharmacol Sci 2019; 23 (9): 3664-3671-DOI: 10.26355/eurrev_201905_17790-PMID: 31114991 has been retracted in accordance with the Publisher and the Editor in Chief. The article has been retracted due to a critical error in the methodology. Specifically, the primers reported as targeting the SNHG14 gene were incorrect. A BLAST alignment of the cited primer sequences revealed that they do not significantly align with SNHG14, but instead match sequences from TALAM1/MALAT1. This error compromises the validity of the study's results. Therefore, the manuscript has been retracted. The authors were notified of the investigation and were asked to provide the raw data, but they have not responded. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/17790.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 4","pages":"151"},"PeriodicalIF":3.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202504_37158","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
The article "LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis" by Y.-Y. Zhang, M. Li, Y.-D. Xu, J. Shang published in Eur Rev Med Pharmacol Sci 2019; 23 (9): 3664-3671-DOI: 10.26355/eurrev_201905_17790-PMID: 31114991 has been retracted in accordance with the Publisher and the Editor in Chief. The article has been retracted due to a critical error in the methodology. Specifically, the primers reported as targeting the SNHG14 gene were incorrect. A BLAST alignment of the cited primer sequences revealed that they do not significantly align with SNHG14, but instead match sequences from TALAM1/MALAT1. This error compromises the validity of the study's results. Therefore, the manuscript has been retracted. The authors were notified of the investigation and were asked to provide the raw data, but they have not responded. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/17790.
期刊介绍:
European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research.
The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine.
European Review for Medical and Pharmacological Sciences includes:
-Editorials-
Reviews-
Original articles-
Trials-
Brief communications-
Case reports (only if of particular interest and accompanied by a short review)